Cargando…

A Pillar and Perfusion Plate Platform for Robust Human Organoid Culture and Analysis

Human organoids have potential to revolutionize in vitro disease modeling by providing multicellular architecture and function that are similar to those in vivo. This innovative and evolving technology, however, still suffers from assay throughput and reproducibility to enable high-throughput screen...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Soo-Yeon, Kimura, Masaki, Shrestha, Sunil, Lewis, Phillip, Lee, Sangjoon, Cai, Yuqi, Joshi, Pranav, Acharya, Prabha, Liu, Jiafeng, Yang, Yong, Sanchez, J. Guillermo, Ayyagari, Sriramya, Alsberg, Eben, Wells, James M., Takebe, Takanori, Lee, Moo-Yeal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10055006/
https://www.ncbi.nlm.nih.gov/pubmed/36993405
http://dx.doi.org/10.1101/2023.03.11.532210
Descripción
Sumario:Human organoids have potential to revolutionize in vitro disease modeling by providing multicellular architecture and function that are similar to those in vivo. This innovative and evolving technology, however, still suffers from assay throughput and reproducibility to enable high-throughput screening (HTS) of compounds due to cumbersome organoid differentiation processes and difficulty in scale-up and quality control. Using organoids for HTS is further challenged by lack of easy-to-use fluidic systems that are compatible with relatively large organoids. Here, we overcome these challenges by engineering “microarray three-dimensional (3D) bioprinting” technology and associated pillar and perfusion plates for human organoid culture and analysis. High-precision, high-throughput stem cell printing and encapsulation techniques were demonstrated on a pillar plate, which was coupled with a complementary deep well plate and a perfusion well plate for static and dynamic organoid culture. Bioprinted cells and spheroids in hydrogels were differentiated into liver and intestine organoids for in situ functional assays. The pillar/perfusion plates are compatible with standard 384-well plates and HTS equipment, and thus may be easily adopted in current drug discovery efforts.